LYB
NYSE · Chemicals
Lyondellbasell Indu-Cl A
$59.59
-1.85 (-3.01%)
Financial Highlights (FY 2026)
Revenue
31.19B
Net Income
-763,355,775
Gross Margin
8.5%
Profit Margin
-2.5%
Rev Growth
-15.8%
D/E Ratio
1.28
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 8.5% | 8.5% | 40.1% | 40.1% |
| Operating Margin | -1.4% | -1.3% | 11.7% | 12.6% |
| Profit Margin | -2.5% | -2.3% | 13.4% | 14.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 31.19B | 37.03B | 7.30B | 8.08B |
| Gross Profit | 2.67B | 3.17B | 2.92B | 3.24B |
| Operating Income | -439,769,695 | -469,895,198 | 854.25M | 1.02B |
| Net Income | -763,355,775 | -815,647,865 | 974.42M | 1.18B |
| Gross Margin | 8.5% | 8.5% | 40.1% | 40.1% |
| Operating Margin | -1.4% | -1.3% | 11.7% | 12.6% |
| Profit Margin | -2.5% | -2.3% | 13.4% | 14.7% |
| Rev Growth | -15.8% | -15.8% | +6.8% | +9.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 5.58B | 5.58B | 1.19B | 1.20B |
| Total Equity | 4.35B | 4.35B | 7.44B | 7.52B |
| D/E Ratio | 1.28 | 1.28 | 0.16 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 997.14M | 1.12B | 1.33B | 1.49B |
| Free Cash Flow | — | — | 1.05B | 1.41B |